US must reconsider its reliance on unadjuvanted H1N1, asserts Lancet editorial
04 August 2009
Nancy Faigen
An editorial in the Lancet has criticised the plans of US officials to rely on unadjuvanted vaccines against the novel A(H1N1) virus – and says that "the US must support the use of dose-sparing strategies to avoid depletion of an already short vaccine supply".
A global response...
Please Login to read the full article.
04 August 2009
Nancy Faigen
A global response...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Obama jobs push may bode well for patent reform
- US Capitol Capsule: PhRMA hopes Part D savings will be muscle against 'Super Congress' cuts
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
- US Capitol Capsule: IOM focus on affordable 'essential' benefits expected to stir debate on drug prices
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
